CLINICAL_TRIALS
trial_result
· 2011-02-08
Clinical Trial Update: Alfuzosin Treatment in Children and Adolescents With Neurogenic Urinary Bladder Dysfunction [Phase 3]
Summary
Phase 3 trial of alfuzosin in children and adolescents with neurogenic bladder dysfunction completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Neurogenic Urinary Bladder | Phase 3 | Status: COMPLETED | Results posted: 2011-02-08